AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitalong M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Alteus Biogenics Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitalong M 50mg/1000mg Tablet

Diabetics with type 2 mellitus may find relief from elevated blood glucose with the dual-action formula of the 50mg/1000mg Sitalong M tablet. This medication helps mitigate serious diabetic complications like vision impairment and kidney damage, potentially lowering the risk of stroke or heart attack. Sitalong M may be used independently or in conjunction with other antidiabetic treatments, and its efficacy is enhanced by a balanced diet and regular physical activity. Dosage is customized based on individual health status, blood sugar readings, and current medication regimen. Consuming this tablet with food minimizes stomach upset. For optimal results, adhere to a consistent daily dosage, avoiding abrupt cessation unless instructed by your physician. Maintaining the prescribed diet and exercise plan is crucial for diabetes management. Common side effects include gastrointestinal distress (diarrhea, nausea, vomiting), headache, and pharyngitis. Concurrent use with insulin or sulfonylureas elevates the risk of hypoglycemia; therefore, familiarizing yourself with its symptoms and management is essential. This medication is not universally appropriate. Individuals with pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption should inform their doctor before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Inform your physician of all medications being taken to ensure compatibility with Sitalong M, and limit alcohol intake due to its potential to reduce blood glucose levels. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Sitalong M 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Sitalong M 50mg/1000mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitalong M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Sitalong M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalong M 50mg/1000mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 50mg/1000mg Sitalong M tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Sitalong M 50mg/1000mg Tablet works:

Sitalong M 50mg/1000mg tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitalong M 50mg/1000mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitalong M 50mg/1000mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Sitalong M 50mg/1000mg tablets while breastfeeding is likely inadvisable. Insufficient human evidence indicates potential drug transfer via breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitalong M 50mg/1000mg tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Sitalong M 50mg/1000mg tablets. Physician consultation is recommended. Close monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely avoid Sitalong M 50mg/1000mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalong M 50mg/1000mg Tablet :

Should you forget to take a Sitalong M 50mg/1000mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalong M 50mg/1000mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Sitalong M 50mg/1000mg Tablet

Sitalong M 50mg/1000mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and increases insulin sensitivity. Sitagliptin, by inhibiting DPP-4, promotes increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Indeed, prolonged Sitalong M 50mg/1000mg Tablet consumption can lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, manifesting as peripheral paresthesia (tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and gait instability. Prophylactic annual Vitamin B12 supplementation is recommended by some investigators to mitigate these risks.
Sitalong M 50mg/1000mg tablets may cause frequent side effects including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe adverse reactions such as lactic acidosis can occur. Prolonged administration might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 50mg/1000mg Tablet ingredient or inactive component should not take this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Indeed, Sitagliptin/Metformin 50mg/1000mg tablets can result in lactic acidosis, a serious medical condition characterized by excessive lactic acid in the bloodstream. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction linked to metformin use, prompting its avoidance in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Manifestations of lactic acidosis may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Sitalong M 50mg/1000mg tablets contain sitagliptin and metformin, acting together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when coupled with a healthy diet and exercise regimen. Metformin reduces hepatic glucose production and enhances insulin responsiveness. Sitagliptin, by suppressing DPP4, promotes increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalong M 50mg/1000mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse events such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 50mg/1000mg Tablet constituent should not use this medication. Similarly, its use is contraindicated in individuals with significant renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 50mg/1000mg tablets with alcohol is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitagliptin/Metformin 50mg/1000mg tablets can result in lactic acidosis, a serious medical condition characterized by excessive lactic acid in the bloodstream. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is uncommon. To mitigate risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and those who consume significant alcohol. Presenting symptoms may encompass muscular aches or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms develop, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitalong M 50mg/1000mg Tablet use can induce Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, can lead to anemia, neurological complications including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, as proposed by some studies, include supplemental Vitamin B12 intake at least annually.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent accidental ingestion by children, pets, or others.
Sitalong M 50mg/1000mg tablets contain sitagliptin and metformin, employed in managing type 2 diabetes. This medication enhances blood sugar control in adults, complementing a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and increases insulin sensitivity. Sitagliptin's action involves DPP4 enzyme inhibition, stimulating pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalong M 50mg/1000mg tablets may cause common side effects including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalong M 50mg/1000mg Tablet constituent should not use this medication. Furthermore, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalong M 50mg/1000mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitalong M 50mg/1000mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates caution in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged use of Sitalong M 50mg/1000mg tablets can indeed lead to Vitamin B12 deficiency. This medication disrupts the body's absorption of Vitamin B12 within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including paresthesia (tingling and numbness in extremities), muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, is recommended by some experts.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitalong M 50mg/1000mg Ta...
194
MRP 225
13% off